(til dra KIZ eu mab asmn)
- Antipsoriatic Agent
- Interleukin-23 Inhibitor
- Monoclonal Antibody
Use: Labeled Indications
Plaque psoriasis: Treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Serious hypersensitivity to tildrakizumab or any component of the formulation
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.